跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TO-317
首页
药物
TO-317
TO-317
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
VARIANT, RECOMBINANT BETA-GLUCOCEREBROSIDASE PROTEINS WITH INCREASED STABILITY AND INCREASED RETAINED CATALYTIC ACTIVITY
CN 105296447 A
申请人: CALLIDUS BIOPHARMA INC
优先权: 2010
CN
US
7 件公开
Regulator
US 8251981 B2
申请人: OLSEN JAMES M
优先权: 2004
US
4 件公开
Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors
US 9873661 B2
申请人: UNIV NEW YORK
优先权: 2012
US
2 件公开
Mimetics of CD4 that inhibit immune response
US 7345020 B2
申请人: UNIV JEFFERSON
优先权: 2004
US
Plasma subtitute injection using hydroxyethyl group amylum as blood plasma dilatancy agent
CN 101081229 B
申请人: SICHUAN KELUN PHARMACEUTICAL
优先权: 2006
CN
Pharmaceutical composition with effects of clearing throat, reducing swelling and alleviating pain
CN 101721614 B
申请人: JILIN AODONG YANBIAN PHARMACEUTICAL CO LTD
优先权: 2009
CN
POLYPEPTIDE INVOLVED IN MORPHOGENESIS AND/OR ENVIRONMENTAL STRESS RESISTANCE OF PLANT
US 2015033408 A1
申请人: RIKEN
优先权: 2012
US
External traditional Chinese medical tincture for curing soft tissue pain
CN 106265997 A
申请人: UNIV HUAIHUA
优先权: 2015
CN
Anti-PD-1 antibody and stable preparation thereof
CN 113929781 A
申请人: MABWELL SHANGHAI BIOTECHNOLOGY CO LTD
优先权: 2020
CN
Antibody detection kit based on porcine delta coronavirus N protein epitope peptide and application thereof
CN 116444630 A
申请人: UNIV SICHUAN AGRICULTURAL
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈